Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
about
Redox-directed cancer therapeutics: molecular mechanisms and opportunitiesSickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal responseBiliverdin reductase: new features of an old enzyme and its potential therapeutic significancePolymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation.Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in miceUpregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity.Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.Heme oxygenase-1 system and gastrointestinal tumorsEnhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo.Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of miceProtection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Synthesis, spectroscopic, and cellular properties of α-pegylated cis-A2B2- and A3B-types ZnPcsCombination drug delivery approaches in metastatic breast cancerHeme oxygenase-1 in tumors: is it a false friend?The expression of heme oxygenase-1 in human-derived cancer cell lines.Syntheses and Photodynamic Activity of Pegylated Cationic Zn(II)-Phthalocyanines in HEp2 Cells.The role of heme oxygenase-1 in pulmonary diseaseHO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation.Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compoundsImplication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy.Tumor-targeted induction of oxystress for cancer therapy.Polymer-drug conjugates as modulators of cellular apoptosis.Hemin and Zinc Protoporphyrin IX Affect Granisetron Constipating Effects In Vitro and In Vivo.Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cellsZinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition.4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.Role of glutathione in cancer progression and chemoresistance.Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.Heme Oxygenases in Cardiovascular Health and Disease.A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.Carbon monoxide mediates the anti-apoptotic effects of heme oxygenase-1 in medulloblastoma DAOY cells via K+ channel inhibition.Involvement of heme oxygenase-1 in Korean colon cancer.The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1.Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase.Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
P2860
Q24645584-90D1886F-87E1-42A4-AF5D-8570887DC7FDQ27324518-742550B2-F72A-4804-85BB-9529A29B3A11Q28268811-C4C8C8BF-1532-45C1-8072-C63B7C051662Q33292829-BFDB0A2A-EE90-4236-8E51-2B5E5728E78EQ33351064-44D35EA9-5270-4672-8652-294E4E429FFCQ33823217-D4D094B8-B0DB-413A-88C1-D8AEA79B0405Q33887033-AF388D6D-AB83-4D06-B3DD-6941567037BAQ33894199-305F4027-DAB5-4F5F-BD3C-B169FF2CFDF7Q34355839-BEB6DE95-1BA6-48AF-B81F-1D008ECACEA7Q34584347-E4903089-75CE-4676-BBE5-0980127B9C15Q35099351-91BE10E4-987E-4855-B674-B8FBE22267D0Q35194850-822892A3-2A8F-40AE-A7C2-93FE87F7F5FCQ35569881-23F362A4-D0A6-4CCC-9627-F5D28D25353FQ35640339-EBB44773-2D6F-44BE-A683-7CDB6EEE7DAFQ35694521-3A03FBC4-8B18-4058-AC27-1D3D03775C20Q35955198-EF891049-2D30-4E86-AC7F-0CBF32ED2D53Q36174178-438F5BF2-298B-4E36-B464-70E92F4D4B92Q36314278-E8861453-8892-47BD-BC12-0D43340A0E45Q36329645-7EC79795-8D74-4594-81FD-8A301E20BF01Q36330628-780DB8C6-8B08-41C9-813D-DAD8E1A20B35Q36336147-24E63B23-B368-4BAF-A2C7-8ED555CBEF90Q36591335-6DBEC9CE-5381-4164-BE5B-D4B3BB91CDFFQ36793627-C6818F69-F360-4944-9360-4DC16AEB7FD9Q36900213-5D9D8811-1E81-448F-86F3-C28B0F127416Q36956674-D3AA5590-5019-4BE7-90EE-27DCA2748EFBQ36995261-4605EC49-14C2-48DB-9779-4FDDDBD53FD4Q37219066-E1FF5907-CA2D-471D-8C27-12E0424B808DQ37479305-F9DC95D4-3471-453F-9D54-5451C67E8B03Q37702145-365BF52F-458D-43FB-B8DA-D59651E857C7Q38114436-C12F70E0-0037-4D0D-8040-007A69D65F7BQ38806847-C37D9058-330F-43DC-9CA6-0BB76E83854EQ38823562-0DB140CF-6365-4F26-8FDB-4A5F9245C892Q38953565-6FF952E2-15B7-4CFF-9680-DFA9464D9C6FQ39346874-010EC491-1575-48CA-A559-B8448654FEAEQ39402134-FEAB706D-CD8A-4598-91F5-27F6BA2E4F32Q39590488-F4218BC5-3E38-4594-AE7D-CF6AD3B970A1Q39695809-D048C2D4-9B48-4EDA-A065-B140BDC36FDCQ40064331-F878650F-7740-4641-9244-EE562262FED7Q40236612-34016F55-4208-4372-8864-76EE87065863Q41882913-393FAAE5-BE6E-424C-9AED-7CDF9F5DAE75
P2860
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Enhancement of chemotherapeuti ...... pegylated zinc protoporphyrin.
@en
type
label
Enhancement of chemotherapeuti ...... pegylated zinc protoporphyrin.
@en
prefLabel
Enhancement of chemotherapeuti ...... pegylated zinc protoporphyrin.
@en
P2093
P2860
P356
P1476
Enhancement of chemotherapeuti ...... pegylated zinc protoporphyrin
@en
P2093
Hiroshi Maeda
Takaaki Akaike
Tomohiro Sawa
P2860
P356
10.1002/IJC.11644
P577
2004-03-01T00:00:00Z